Medicinerestricted

Amprenavir

HIV protease inhibitor for treatment-experienced patients.

Clinical information

Common uses

HIV-1 infection, combined with other antiretrovirals
adults and children over 4 years
usually boosted with low-dose ritonavir

Cautions

withdrawn — EU marketing authorisation no longer active
choice should be guided by viral resistance testing

Interactions

ritonavir (used deliberately to boost amprenavir levels)

Reference information, not medical advice — always follow your doctor or pharmacist. Source: EMA, ema.europa.eu, Agenerase (amprenavir) EPAR — withdrawn (accessed 2026-08-16)

Approved brands & formulations3

Brand name	Dosage form	Strength	Importer	Category
Amprenavir	Oral Liquid	150 mg	—	restricted
Amprenavir	Oral Liquid	100 mg	—	restricted
Amprenavir	Oral Liquid	300 mg	—	restricted